Truthout
FDA
Federal Judge Postpones Lawsuit Over Revoking Mifepristone Access After Election
The lawsuit seeks to revoke FDA approval of the abortion drug despite repeated studies that find it safe and effective.
Infant Formula Manufacturers Decide Whether to Inform FDA About Possible Harm
A former attorney for a formula manufacturer facing many lawsuits now leads the FDA.
Trump Uses Full Weight of Federal Government to Restrict Gender-Affirming Care
Several federal agencies have taken unprecedented steps to keep physicians from providing care to trans youth.
For Second Time in 7 Months, Baby Formula Linked to Infant Botulism Is Recalled
The recalls have fueled concerns about the safety of infant formula and the effectiveness of federal oversight.
Congenital Syphilis Skyrockets as US Has Shortage of Drug That Treats It
“We’re talking about the US not being able to make the drug penicillin. Which is ridiculous,” said one expert.
Tobacco Company Gave $5M to Trump PAC Days Before FDA OK’d Flavored Vapes
A recently filed financial report shows Reynolds Americans donated to the super PAC MAGA Inc. in April.
Trump’s FDA Chief Is Pushed Out. Acting Head Is Nonscientist Friend of Don Jr.
Mass layoffs and the loss of scientific expertise had already thrown the Food and Drug Administration in turmoil.
Temporary Supreme Court Stay Restores Mail Access to Mifepristone for 1 Week
A court had previously blocked an FDA rule allowing telehealth prescriptions for the abortion drug.
Sen. Josh Hawley’s Bill Would Undo Federal Approval of Mifepristone Nationwide
Bills in Alaska, Kentucky, Oklahoma, Mississippi, South Dakota, and West Virginia also target medication abortion.
The FDA’s Lax Generic Drug Rules Can Put Patients’ Lives at Risk
Generic drugs are supposed to be equivalent to brand-name medications — but the FDA doesn’t always ensure that.